ARTICLE | Company News

Alexion founder Bell to retire as CEO

January 30, 2015 2:46 AM UTC

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) said principal founder Leonard Bell will retire as CEO, effective April 1, while remaining chairman.

COO David Hallal, who joined Alexion in 2006, will succeed Bell as CEO. Hallal took a board seat and was promoted to COO from EVP and chief commercial officer last September. He previously held commercial roles at OSI Eyetech Inc., Biogen Idec Inc. (NASDAQ:BIIB) and Amgen Inc. (NASDAQ:AMGN). ...